Vetsys Pharmaceutical
Vetsys Pharmaceutical
Azerbaijan's agricultural sector is undergoing a profound transformation. As part of the national "Strategic Roadmap for the Production and Processing of Agricultural Products," the livestock industry in regions like Ganja-Dashkasan, Aran, and Sheki-Zagatala is rapidly modernizing. With the increase in large-scale dairy farming operations, the demand for high-efficacy Intramammary Infusions has skyrocketed.
Mastitis remains the most significant economic challenge for Azerbaijani dairy farmers, leading to reduced milk yield and compromised quality. As a leading supplier, we understand the local climate and the specific pathogens prevalent in the Caucasus region. Our intramammary solutions are designed to address both clinical and subclinical mastitis, ensuring that the burgeoning "Made in Azerbaijan" dairy brand maintains international quality standards.
Zhengzhou Vetsys Pharmaceutical Co., Ltd. (Vetsys), established in 2005, stands as a titan in the animal pharmaceutical industry. With a registered capital of 30 million RMB and state-of-the-art production facilities, we have bridged the gap between scientific innovation and field application.
Our facility includes specialized workshops for producing a comprehensive range of products, including powders, premixes, injections, and our flagship intramammary infusions. By 2015, Vetsys achieved annual sales exceeding USD 20 million, cementing our position as a top-tier producer in China with a growing footprint in Azerbaijan and Central Asia.
What sets Vetsys apart is our relentless pursuit of innovation. Our independent research institute houses five specialized laboratories staffed by world-class scientists. We utilize AI-enhanced molecular modeling to improve the bioavailability of our infusions, ensuring that active ingredients like Cefquinome Sulfate and Amoxicillin reach the infection site with precision.
Quality is the cornerstone of our operations. We adhere to rigorous Good Manufacturing Practices (GMP) and ISO standards. For our Azerbaijani partners, this means every syringe of intramammary infusion undergoes extensive quality control checks to meet both local regulations and international safety benchmarks.
The veterinary medicine market in Azerbaijan is shifting away from broad-spectrum oral antibiotics toward localized Intramammary Infusions. This trend is driven by several factors:
Vetsys is not only focused on efficacy but also environmental well-being. We invest in green manufacturing technologies to minimize waste. For the Azerbaijani market, where agricultural land is a precious resource, our sustainable practices ensure that animal health does not come at the cost of environmental health.
At Vetsys, we are driven by our mission to improve animal health through continuous innovation, world-class quality, and sustainable practices. We are actively exploring international expansion, aiming to bring high-quality, innovative animal health solutions to global markets including Azerbaijan. Our future strategy includes partnerships and expanding our manufacturing capabilities to meet the increasing demand for safe and effective animal drugs worldwide.
